NCT01922843View on ClinicalTrials.gov

A Phase 2 Study of an Oral Vitamin D Compound (DP001) in Secondary Hyperparathyroidism in Patients on Hemodialysis

PHASE2CompletedINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

May 31, 2014

Study Completion Date

June 30, 2014

Conditions
Hyperparathyroidism, SecondaryKidney Failure, Chronic
Interventions
DRUG

DP001 softgel capsules

DRUG

Placebo

Trial Locations (14)

Unknown

Phoenix

Tucson

Washington D.C.

Evanston

St Louis

Las Vegas

Great Neck

Ridgewood

Charlotte

Cincinnati

Nashville

Fort Worth

Grand Prairie

San Antonio

Sponsors
All Listed Sponsors
lead

Deltanoid Pharmaceuticals

INDUSTRY